Trial Profile
A multicenter, double-blind, placebo-controlled, randomized study of the analgesic efficacy and safety of valdecoxib 20 mg QD and valdecoxib 20 mg BID compared to placebo over multiple days for management of acute postsurgical pain in patients undergoing anterior cruciate ligament reconstruction
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 10 Nov 2021
Price :
$35
*
At a glance
- Drugs Valdecoxib (Primary)
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Pfizer
- 16 Apr 2008 New trial record.